Journal of Ophthalmology
Scope & Guideline
Transforming Ophthalmology with Cutting-Edge Insights
Introduction
Aims and Scopes
- Clinical Ophthalmology:
Research related to the diagnosis, treatment, and management of various ocular conditions, including cataracts, glaucoma, age-related macular degeneration, and diabetic retinopathy. - Surgical Techniques:
Innovative surgical methods and outcomes in ocular procedures, particularly in cataract surgery, retinal surgery, and glaucoma management. - Ocular Pathophysiology:
Studies focusing on the underlying mechanisms and biological processes of eye diseases, including genetic, molecular, and inflammatory aspects. - Optical Imaging Technologies:
Advancements in imaging techniques such as optical coherence tomography (OCT) and their applications in diagnosing and monitoring ocular diseases. - Public Health and Epidemiology:
Research exploring the prevalence, risk factors, and socio-economic determinants of eye diseases and their impact on public health. - Innovative Therapies and Treatments:
Evaluation of new therapeutic approaches, including pharmacologic treatments, gene therapy, and minimally invasive techniques. - Patient-Reported Outcomes:
Research that assesses patient experiences and quality of life related to ophthalmic conditions and treatments.
Trending and Emerging
- Artificial Intelligence in Ophthalmology:
There is a significant increase in research applying artificial intelligence for diagnosing and managing ocular diseases, highlighting the potential for improved accuracy and efficiency in clinical practice. - Telemedicine and Remote Monitoring:
The rise of teleophthalmology, especially post-COVID-19, emphasizes the importance of remote patient monitoring and virtual consultations in maintaining eye health. - Genetic and Molecular Research:
An increasing focus on genetic studies and molecular mechanisms underlying eye diseases, which can lead to targeted therapies and personalized medicine. - Ocular Imaging Innovations:
Emerging imaging technologies, such as enhanced optical coherence tomography and multimodal imaging, are gaining traction for their ability to provide detailed insights into ocular health. - Myopia Management:
Research on interventions for myopia control, including innovative spectacle designs and pharmacological treatments, is becoming a prominent area of interest. - Social Determinants of Eye Health:
A growing body of work addressing the impact of socio-economic factors on ocular health outcomes, emphasizing the need for equitable access to eye care services.
Declining or Waning
- Traditional Pharmacotherapy:
There appears to be a waning interest in studies focused solely on traditional pharmacotherapy, as newer therapies and combination treatments gain prominence. - Invasive Surgical Procedures:
Research on highly invasive surgical techniques is becoming less frequent, with a shift toward less invasive, more patient-friendly approaches. - Aging Population Studies:
While still important, the volume of studies specifically targeting aging-related ocular conditions without broader implications or innovative treatment options has decreased. - Historical Epidemiological Studies:
The journal has seen fewer publications focused on retrospective epidemiological studies, as there is a growing emphasis on real-time data and prospective analyses. - Conventional Visual Acuity Testing:
There is a notable reduction in research centered on conventional visual acuity testing methods, as advancements in technology offer more comprehensive assessment tools.
Similar Journals
EXPERIMENTAL EYE RESEARCH
Illuminating the Path of Ophthalmology and NeuroscienceEXPERIMENTAL EYE RESEARCH, published by Academic Press Ltd - Elsevier Science Ltd, is a preeminent journal dedicated to advancing the fields of ophthalmology and neuroscience. With a history of insightful publications dating back to 1961, this journal serves as a critical platform for researchers, professionals, and students interested in the cellular and molecular mechanisms underlying visual processes. The journal boasts impressive rankings, including being placed in the top quartile (Q1) of both the Ophthalmology and Sensory Systems categories, and is recognized in the 2nd quartile (Q2) for Cellular and Molecular Neuroscience. With an impact factor reflecting its significant contribution to the field, EXPERIMENTAL EYE RESEARCH is a valuable resource that promotes the exchange of innovative research and ideas essential for understanding the complexities of eye function and vision-related disorders. Researchers looking to publish their findings or stay abreast of the latest studies will find this journal a vital component of their academic toolkit.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Pioneering Insights for Visionary CareRETINA - THE JOURNAL OF RETINAL AND VITREOUS DISEASES is a premier peer-reviewed journal dedicated to advancing the knowledge and practice of retinal and vitreous disorders. Published by LIPPINCOTT WILLIAMS & WILKINS, this esteemed journal boasts a significant impact factor, affirming its standing in the academic community. With a long history of publication since 1981, its scope covers cutting-edge research and innovations aimed at improving patient outcomes in ophthalmology. As evidenced by its recent categorization in the Q1 quartile for both Medicine (miscellaneous) and Ophthalmology in 2023, the journal ranks impressively, placing it in the 84th percentile among its peers. Researchers, clinicians, and students will find valuable insights and evidence-based articles that contribute to the ever-evolving landscape of retinal health. RETINA remains committed to fostering an environment for scholarly dialogue and dissemination of knowledge, ensuring its readers are at the forefront of advancements in their field.
Augenheilkunde Up2date
Advancing Insights in Ophthalmology.Augenheilkunde Up2date is a pivotal journal in the field of ophthalmology, published by GEORG THIEME VERLAG KG, a renowned publisher known for its commitment to advancing medical knowledge. With its ISSN 1616-9719 and E-ISSN 1616-9735, this journal serves as a vital resource for researchers, professionals, and students interested in the latest developments and nuanced discussions in eye health. Although not available as open access, its curated content offers significant insights into contemporary research, clinical practices, and emerging trends in ophthalmology, thus promoting the continuous professional development of its readers. There is an emphasis on providing comprehensive reviews that encapsulate the pertinent advancements in the field, making it an essential publication for those aiming to enhance their expertise in eye care and vision science.
JAMA Ophthalmology
Exploring Innovations for Visionary OutcomesJAMA Ophthalmology, the premier journal in the field of ophthalmology, is published by the esteemed American Medical Association. Renowned for its rigorous peer-review process and commitment to advancing eye health research, JAMA Ophthalmology holds a prestigious position in the scientific community, boasting an impressive impact factor and ranking as Q1 in the category of Ophthalmology. With a Scopus rank of #3 out of 137 in its field and a remarkable 98th percentile, the journal serves as an invaluable resource for researchers, healthcare professionals, and students dedicated to the ophthalmic sciences. Readers can explore a wealth of cutting-edge findings, clinical studies, and review articles that not only contribute to the sustainable advancement of ophthalmic knowledge but also foster innovative approaches in patient care. As we converge into 2024, the journal continues to embrace open access principles, ensuring that groundbreaking research is readily available to a global audience, enhancing collaborative efforts and furthering the development of the ophthalmology discipline.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
Fostering collaboration for ocular excellence.Investigative Ophthalmology & Visual Science (IOVS) is a leading academic journal published by the Association for Research in Vision and Ophthalmology, dedicated to advancing the field of ophthalmology and visual science. With an impressive impact factor and ranking in the Q1 category for both Ophthalmology and Sensory Systems, IOVS is well-respected for disseminating cutting-edge research and innovative discoveries. Established in 1977, this Open Access journal allows for broad accessibility to pioneering studies, fostering collaboration among researchers, clinicians, and students. The journal has consistently maintained high visibility in the academic community, evidenced by its robust rankings in Scopus, including Rank #16 in Ophthalmology. As it continues to pave the way for future developments in the understanding and treatment of ocular diseases, IOVS serves as an invaluable resource for those immersed in the complex field of visual science.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
Exploring New Horizons in Eye HealthCLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is a leading peer-reviewed journal published by Wiley, renowned for its commitment to advancing the field of ophthalmology. With an impressive impact factor reflecting its high-quality research contributions, this journal is ranked in the Q1 category both in Medicine (miscellaneous) and Ophthalmology, signifying its crucial role in shaping contemporary ophthalmic research. It boasts a remarkable position in the Scopus Ranks, standing at Rank #13 out of 137 in the field of Medicine and Ophthalmology, placing it within the 90th percentile among its peers. Having been in circulation since 1979, this journal encompasses a broad scope of topics that aim to disseminate groundbreaking findings and stimulate dialogue among researchers, clinicians, and students alike. It is easily accessible to a global audience, embodying the principles of open access, making valuable research available to all. For anyone seeking to stay at the forefront of ophthalmology, CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is an indispensable resource that fosters knowledge and innovation in the ever-evolving landscape of eye care.
Translational Vision Science & Technology
Elevating Research in Vision Science and Biomedical EngineeringTranslational Vision Science & Technology is a premier open access journal dedicated to the advancement of the field of ophthalmology and biomedical engineering. Published by the Association for Research in Vision and Ophthalmology, Inc., this journal has established itself as a leading source of high-quality research since its inception in 2013, achieving a remarkable impact factor reflective of its influential contribution to the field. With an impressive ranking of #21 in Ophthalmology and #120 in Biomedical Engineering within the Scopus database, it sits within the prestigious Q1 quartile for both categories as of 2023, further validating its significance. The journal's scope encompasses a wide variety of topics focused on the intersection of ophthalmological science and technological innovation, welcoming contributions that promote the understanding and treatment of visual disorders. Available as an Open Access publication since 2016, it ensures that cutting-edge research is freely accessible to researchers, practitioners, and students worldwide, facilitating the rapid dissemination of knowledge essential for the advancement of vision science.
EUROPEAN JOURNAL OF OPHTHALMOLOGY
Advancing Eye Health Through Innovative ResearchThe EUROPEAN JOURNAL OF OPHTHALMOLOGY, published by SAGE PUBLICATIONS LTD, is a leading international journal in the field of ophthalmology, dedicated to advancing the understanding and treatment of ocular diseases and disorders. With an ISSN of 1120-6721 and an E-ISSN of 1724-6016, the journal aims to provide a platform for innovative research, critical reviews, and comprehensive studies that span the diverse aspects of the discipline. As part of its commitment to disseminating high-quality research, the journal is indexed in Scopus, achieving an impressive rank of #47 out of 137 in the Medicine - Ophthalmology category, indicating its strong impact within the academic community. With a current impact factor that places it in the Q2 quartile for both Medicine (miscellaneous) and Ophthalmology as of 2023, it offers researchers and practitioners access to important findings and developments in eye health. The journal's converged years from 1991 to 2024 exemplify its longstanding commitment to the field, making it an essential resource for anyone looking to stay at the forefront of ophthalmological research.
CURRENT OPINION IN OPHTHALMOLOGY
Transforming Knowledge into Clinical Practice.CURRENT OPINION IN OPHTHALMOLOGY is a premier academic journal published by Lippincott Williams & Wilkins, focusing on the dynamic and evolving field of ophthalmology. With an impressive impact factor and a prestigious Q1 ranking in both Medicine (miscellaneous) and Ophthalmology for 2023, this journal is recognized for its authoritative reviews and critical summaries of contemporary research. Since its inception in 1990, the journal has served as an essential resource for ophthalmology professionals, providing insights into the latest advances in clinical practices, emerging technologies, and cutting-edge research. Although not open access, it is highly regarded for its rigorous peer-review process, ensuring the publication of high-quality, relevant findings. Researchers, clinicians, and students alike will find invaluable perspectives in its pages as they navigate the complexities of eye health and patient care.
Ophthalmology Science
Leading the Way in Ophthalmic InnovationOphthalmology Science is a premier journal published by Elsevier, dedicated to advancing the field of ophthalmology through innovative research and clinical insights. With an impact factor that positions it in the Q1 category of ophthalmology journals, it stands out as a crucial resource for researchers, clinicians, and students alike. The journal, indexed under ISSN 2666-9145, covers a wide array of topics relevant to eye care, encompassing the latest breakthroughs in diagnostics, therapeutics, and surgical techniques. Operating in the United States from its office in Amsterdam, the journal aims to bridge the gap between laboratory findings and clinical applications, contributing to improved patient outcomes globally. The converged years from 2021 to 2024 reflect its commitment to providing timely and impactful research that shapes the future of ophthalmic practice. Make sure to explore the open access options available for wider dissemination of your work and to stay ahead in the evolving landscape of ophthalmology.